Karen A. Arias Soler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Karen A. Arias Soler has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Agobardo Cárdenas-Chaparro
Universidad Pedagógica y Tecnológica de Colombia Tunja Boyacá Colombia
1 shared publication - Diana L. Nossa González
CEQUINOR (UNLP‐CONICET, CCT‐La Plata, associated with CIC) Departamento de Química Facultad de Ciencias Exactas Universidad Nacional de La Plata Boulevard 120 No 1465 1900 La Plata República Argentina
1 shared publication - Jovanny Arles Gómez Castaño
Grupo Química-Física Molecular y Modelamiento Computacional (QUIMOL), Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia, Sede Central, Avenida Central del Norte, Tunja 150003, Colombia
1 shared publication - Lina S. Prieto Cárdenas
Grupo Química-Física Molecular y Modelamiento Computacional (QUIMOL), Facultad de Ciencias, Universidad Pedagógica y Tecnológica de Colombia (UPTC), Avenida Central del Norte, Tunja 050030, Colombia
1 shared publication - Pablo R. Duchowicz
Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), CONICET, UNLP, La Plata, Argentina
1 shared publication - Wilson Rozo
Department of Chemistry, Universidad Pedagógica y Tecnológica de Colombia, Colombia
1 shared publication
Latest Publications
- Open Access
- 31 May 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (6) , 687
In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
Chagas and leishmaniasis are two neglected diseases considered as public health problems worldwide, for which there is no effective, low-cost, and low-toxicity treatment for the host. Naphthoquinones are ligands with redox properties involved in oxidative biological processes with a wide variety of activities, including antiparasitic. In this work, in silico methods of quantitative structure–activity relationship (QSAR), molecular docking, and calculation of ADME (absorption, distribution, metabolism, and excretion) properties were used to evaluate naphthoquinone derivatives with unknown antiprotozoal activity. QSAR models were developed for predicting antiparasitic activity against Trypanosoma cruzi, Leishmania amazonensis, and Leishmania infatum, as well as the QSAR model for toxicity activity. Most of the evaluated ligands presented high antiparasitic activity. According to the docking results, the family of triazole derivatives presented the best affinity with the different macromolecular targets. The ADME results showed that most of the evaluated compounds present adequate conditions to be administered orally. Naphthoquinone derivatives show good biological activity results, depending on the substituents attached to the quinone ring, and perhaps the potential to be converted into drugs or starting molecules.
- 31 May 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (6) , 687
Open AccessIn Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
Chagas and leishmaniasis are two neglected diseases considered as public health problems worldwide, for which there is no effective, low-cost, and low-toxicity treatment for the host. Naphthoquinones are ligands with redox properties involved in oxidative biological processes with a wide variety of activities, including antiparasitic. In this work, in silico methods of quantitative structure–activity relationship (QSAR), molecular docking, and calculation of ADME (absorption, distribution, metabolism, and excretion) properties were used to evaluate naphthoquinone derivatives with unknown antiprotozoal activity. QSAR models were developed for predicting antiparasitic activity against Trypanosoma cruzi, Leishmania amazonensis, and Leishmania infatum, as well as the QSAR model for toxicity activity. Most of the evaluated ligands presented high antiparasitic activity. According to the docking results, the family of triazole derivatives presented the best affinity with the different macromolecular targets. The ADME results showed that most of the evaluated compounds present adequate conditions to be administered orally. Naphthoquinone derivatives show good biological activity results, depending on the substituents attached to the quinone ring, and perhaps the potential to be converted into drugs or starting molecules.